This website uses first-party and third-party cookies to enhance our services and show you information related to your preferences by analysing your browsing habits. By continuing to browse our website you accept our use of cookies. You can change the settings or get more information by visiting our Cookies Policy.

Publications of our products in the last years:


Tasectan ®

PUBLICATION

 

MAGAZINE/CONGRESS

     
Allegrini A. & Constantini M., “Gelatine Tannate for the treatment of Acute Diarrhoea in Adults”   J Gastroint Dig Syst 2012, 2:3.
     
Guzganu I., “Severe Diarrhea in a 4-month-old baby girl with acute gastroenteritis: a case report and review of the literature”

 

Case Reports in Gastrointestinal Medicine, Volume 2012.
     
Allegrini A. et al. “Tasectan (gelatine tannate) for the treatment of acute gastroenteritis in children: Preliminary results from a study conducted to evaluate its efficacy and safety”   Poster published at the 39th annual paediatric Belgium society congress, Brussels, March 2011
     
Carretero et al, “A comparative analysis of response to ORS (oral rehydration solution) vs. ORS + gelatine tannate in two cohorts of paediatric patients with acute diarrhoea”

 

Rev. Esp. Enferm. Dig, Vol.101 Nº1, pp. 41-48, 2009.
     
Durban Reguera F. et al, “Prospective Observational Study on Infants and children with Acute Diarrhoea treated with gelatine tannate”.

 

Poster Published at “Semana de las Enfermedades Digestivas” in Madrid (Spain), June 2007.
     
Durban Reguera F. et al, “Prospective Observational Study on Adults with Acute Diarrhoea treated with gelatine tannate”.

 

Poster Published at “Semana de las Enfermedades Digestivas” in Madrid (Spain), June 2007.
     

Freli V. et al, "New insights into the mechanism of action of gelatine tannate for acute diarrhoea. Part 1: film-forming effect".

 

Presented as oral communication at the 33rd edition of the Congress from the Groupe Francophone d'Hépato-Gastroentérologie et Nutrition Pédiatriques in Nantes, France, on 30th March 2012.
     
De Servi B, et al., “New insights into the mechanism of action of gelatine tannate for acute diarrhoea. Part 2: antibacterial activity”.

 

Presented as oral communication at the 33rd edition of the Congress from the Groupe Francophone d'Hépato-Gastroentérologie et Nutrition Pédiatriques in Nantes, France, on 30th March 2012.
     
L. Bueno et al, “Undissociated Gelatine Tannate reduces intestinal leakiness and mucosa inflammation by forming a protective biofilm: results from in- vitro and in-vivo studies”

 

UEG Journal - United European Gastroenterology Journal, Oct.2013: Vol. 1, Supl. 1; ISSN 2050-6406 (print) ISSN 2050-6414 (online).
     

XilaPlus®

PUBLICATION

 

MAGAZINE/CONGRESS

     
Lucio Gnessi, Vladimir Bacarea, Marius Marusteri and Núria Piqué. Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.   BMC Gastroenterology (2015) 15:153
     
Lucio Gnessi, Xavier Llop, Núria Piqué. Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.

 

23rd UEG WEEK BARCELONA. October 24-28 2015
     
Catalin Pleasea Condratovici, Vladimir C. Bacârea, Núria Piqué. Xyloglucan for the treatment of acute gastroenteritis in children: results of a randomized, controlled, clinical trial.

 

Gastroenterology Research and Practice. April 2016
     
Catalin Pleasea Condratovici, Xavier Llop, Núria Piqué, Vladimir Bacarea. Xyloglucan for the treatment of acute gastroenteritis in children: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.   23rd UEG WEEK BARCELONA. October 24-28 2015
     

Utipro Plus®

PUBLICATION

 

MAGAZINE/CONGRESS

     
Alejandro García-Larrosa and Octavian Alexe. Efficacy and Safety of a Medical Device versus Placebo in the Early Treatment of Patients with Symptoms of Urinary Tract Infection: A Randomized Controlled Trial.   Clin Microbiol 2016, 5:1
     
Nicola Salvatorelli, Alejandro García-Larrosa, Alessandro Allegrini, Daniele Pavone. A New Approach to the Treatment of Uncomplicated Cystitis: Results of a Randomized Placebo-Controlled Clinical Trial.   Urol Int. Published online: April 8, 2016
     
Barbara de Servi1, Francesco Ranzini1 & Nuria Piqué*. Effect of Utipro® (containing gelatin- xyloglucan) against Escherichia coli invasion of intestinal epithelial cells: results of an in vitro study.

 

Future Microbiology. Posted online on March 29, 2016.
     
Hélène Eutamene, Cherryl Harkat, Valérie Bezirard, Vassilia Theodorou. Undissociated gelatin tannate and xyloglucan prevent gut leakiness and mucosal inflammation induced by LPS: Insights in the Mechanism of action.

 

UEG Week. Vienna October 2016.
     
Maïwenn Olier, Soraya Sekkal, Cherryl Harkat, Hélène Eutamène, Vassilia Theodorou, Lionel Bueno. In vivo evaluation of properties of a new medical device against intestinal commensals with uropathogenic potential   American Gastroenterology association congress (May 2016)
     
Alex García-Larrosa. Utipro® un nuevo tratamiento efectivo contra los síntomas de cisititis aguda.

 

Spanish national Urology Congress. Tenerife 2014.
     
Alex García-Larrosa, Xavier Llop. Utipro® is more effective than placebo in reducing recurrent cystitis. Preliminary results.

 

XXI Congresso nazionale AURO II. Roma 2014
     

Gelsectan®

PUBLICATION

 

MAGAZINE/CONGRESS

     
Octavian Alexea, Vlad Bacarea and Nuria Pique. The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.   United European Gastroenterology Journal. June 2016 vol. no. 3 455-465

http://ueg.sagepub.com/content/4/3/455.full.pdf
     
       
This area contains information intended exclusively for health professionals authorized to prescribe or dispense pharmaceutical products.
   
Calle Consejo de Ciento, 333
08007 Barcelona, Spain

Contact us

info@noventure.com
NOVENTURE S.L.
Tel: +34.93.205.27.18